Last quarter (Q3 2024), Medicenna Therapeutics Corp's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Medicenna Therapeutics Corp's net income was C$-4.98M. See Medicenna Therapeutics Corp’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Total Revenue	-	-	-	-	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	C$ 16.99M	C$ 16.30M	C$ 27.38M	C$ 17.39M	C$ 8.24M	C$ 4.73M
Operating Income	C$ -16.99M	C$ -16.30M	C$ -27.38M	C$ -17.39M	C$ -8.24M	C$ -4.73M
Net Non Operating Interest Income Expense	C$ 700.00K	C$ 262.00K	C$ 69.00K	C$ -314.00K	C$ 7.00K	C$ 102.00
Other Income Expense	C$ -1.35M	C$ -4.35M	-	C$ -208.00K	C$ -39.00K	C$ 19.15K
Pretax Income	C$ -15.42M	C$ -10.05M	C$ -27.14M	C$ -17.29M	C$ -8.28M	C$ -4.71M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -15.42M	C$ -10.05M	C$ -27.14M	C$ -17.29M	C$ -8.28M	C$ -4.71M
Basic EPS	C$ -0.16	C$ -0.16	C$ -0.42	C$ -0.35	C$ -0.26	C$ -0.18
Diluted EPS	C$ -0.16	C$ -0.16	C$ -0.42	C$ -0.35	C$ -0.26	C$ -0.18
Basic Average Shares	C$ -63.21B	C$ 64.74M	C$ 54.29M	C$ 49.66M	C$ 31.90M	C$ 25.67M
Diluted Average Shares	C$ -63.21B	C$ 64.74M	C$ 54.29M	C$ 49.66M	C$ 31.90M	C$ 25.67M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 12.21M	-	-	C$ -17.39M	C$ 8.24M	C$ 4.73M
Net Income From Continuing And Discontinued Operation	C$ -15.42M	C$ -10.05M	C$ -27.14M	C$ -17.29M	C$ -8.28M	C$ -4.71M
Normalized Income	C$ -11.33M	C$ -7.39M	C$ -16.59M	C$ -12.71M	C$ -8.24M	C$ -4.73M
Interest Expense	-	-	-	-	-	-
EBIT	C$ -14.77M	C$ -9.40M	C$ -22.58M	C$ -17.29M	C$ -8.24M	C$ -4.73M
EBITDA	C$ -14.76M	C$ -9.39M	C$ -22.54M	C$ -17.25M	C$ -8.24M	C$ -4.72M

Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing